SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-06-071618
Filing Date
2006-04-03
Accepted
2006-04-03 13:11:37
Documents
4
Period of Report
2006-05-11
Effectiveness Date
2006-04-03

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ddef14a.htm DEF 14A 390133
2 GRAPHIC g90839g54e58.jpg GRAPHIC 35778
3 GRAPHIC g90839g59f08.jpg GRAPHIC 9664
4 GRAPHIC g90839g81k54.jpg GRAPHIC 13076
  Complete submission text file 0001193125-06-071618.txt   472554
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-23272 | Film No.: 06732315
SIC: 2836 Biological Products, (No Diagnostic Substances)